Clinical Trial Update: Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery [Phase 4]

View source ↗

Summary

A Phase 4 prospective study assessing safety and efficacy of DEXTENZA following concomitant MIGS and cataract surgery was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Glaucoma

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: The New York Eye Surgery Center | Conditions: Glaucoma, Cataract | Phase 4 | Status: TERMINATED | Results posted: 2024-01-31